Multidistrict Litigation: How Mass Injury Cases Are Managed Federally

Multidistrict litigation (MDL) is a federal procedural mechanism that consolidates civil cases sharing common factual questions into a single district court for coordinated pretrial proceedings. Authorized under 28 U.S.C. § 1407, MDL has become the dominant vehicle for managing mass injury claims arising from defective products, dangerous pharmaceuticals, and large-scale industrial disasters. Understanding how MDL works is essential for anyone researching how the federal court system handles high-volume, multi-plaintiff injury litigation at scale.

Definition and Scope

MDL is a procedural tool — not a substantive cause of action — that allows a single federal judge to preside over the pretrial phase of cases that would otherwise proceed independently in district courts across the country. The governing statute, 28 U.S.C. § 1407, was enacted by Congress in 1968 specifically to address the inefficiency produced when hundreds or thousands of plaintiffs file similar federal suits in different jurisdictions simultaneously.

The Judicial Panel on Multidistrict Litigation (JPML) — a seven-judge body established by the same statute — holds authority to transfer cases into an MDL proceeding when it determines that centralization will serve "the convenience of parties and witnesses and will promote the just and efficient conduct of such actions" (28 U.S.C. § 1407(a)). The transferee court does not retain permanent jurisdiction; once pretrial proceedings conclude, individual cases that have not settled are remanded to their originating districts for trial.

MDL proceedings cover product liability, pharmaceutical injury, aviation disasters, securities fraud, antitrust actions, and environmental mass tort cases. As of 2023, MDL dockets represented approximately 70 percent of all pending federal civil cases, according to data published by the Judicial Panel on Multidistrict Litigation. That concentration illustrates why MDL has effectively become the default architecture of complex federal injury litigation.

Core Mechanics or Structure

The Transfer and Centralization Process

Centralization begins when a party — plaintiff, defendant, or the JPML acting on its own initiative — files a motion to transfer with the JPML. The Panel evaluates whether the cases share "one or more common questions of fact," a threshold set by 28 U.S.C. § 1407(a). Purely legal questions do not satisfy this standard; factual commonality is required.

After briefing and oral argument held in rotating cities, the JPML issues a transfer order identifying both the transferee district and the presiding judge. Selection of the transferee judge is a practical decision driven by judicial experience with complex litigation, geographic convenience, and docket capacity — factors the Panel weighs without a rigid formula.

Leadership Structure

Once an MDL is established, the transferee judge appoints a Plaintiffs' Steering Committee (PSC) and, on the defense side, a Defense Liaison Counsel structure. The PSC — typically 10 to 30 attorneys depending on complexity — coordinates discovery, manages shared litigation expenses, and negotiates with defendants on behalf of the collective plaintiff pool. Individual plaintiffs retain their own attorneys of record but delegate pretrial coordination to PSC counsel.

Bellwether Trials

A defining feature of MDL case management is the bellwether trial. Rather than trying all cases at once, the transferee judge selects a statistically representative sample — often 4 to 10 cases — and tries them to verdict. Bellwether outcomes inform global settlement negotiations by revealing how juries respond to the core liability evidence, allowing both sides to project aggregate exposure. The bellwether mechanism is not codified in § 1407 but has developed through practice and is recognized in Federal Rule of Civil Procedure 16 case management authority.

Remand

Cases that survive pretrial proceedings without settlement are remanded to their originating district courts under 28 U.S.C. § 1407(a) for trial. In practice, fewer than 3 percent of MDL cases reach the remand-for-trial stage, according to empirical research published by the Duke Law Center for Judicial Studies. The overwhelming majority resolve through global settlement before or shortly after bellwether verdicts.

Causal Relationships or Drivers

MDL volume is driven by the convergence of three structural forces. First, product liability law creates national injury pools when defective goods are distributed nationally — a single pharmaceutical distributed across all 50 states can generate thousands of parallel federal suits within months of mass-tort allegations becoming public. Second, removal to federal court by corporate defendants consolidates cases that plaintiffs might prefer to keep in state venues, feeding the federal MDL pipeline. Third, the economics of complex litigation — particularly contingency fee arrangements and the high cost of expert witnesses — make solo prosecution of pharmaceutical or medical device cases prohibitively expensive for individual plaintiff firms, creating incentive for coordinated filing and PSC participation.

Regulatory enforcement actions by agencies such as the Food and Drug Administration (FDA) or the Environmental Protection Agency (EPA) frequently precede MDL formation. A public FDA warning letter, a drug recall, or an EPA consent decree generates document records that plaintiffs use to establish notice and knowledge in discovery, accelerating the filing of cases that aggregate into MDL petitions.

Classification Boundaries

MDL differs from related procedural devices along three critical axes:

MDL vs. Class Action: A class action certifies a class under Federal Rule of Civil Procedure 23, binding absent members to the outcome and requiring commonality, typicality, and adequacy of representation. MDL does not certify a class — each plaintiff remains an individual litigant with a separate case. This distinction controls whether a plaintiff is bound by a settlement: class members are bound (absent opt-out), while MDL plaintiffs must individually consent to resolve their claims.

MDL vs. Joinder: Joinder under Federal Rule of Civil Procedure 20 brings multiple parties into a single case filed in one court. MDL consolidates separately filed cases that originated in different courts. The jurisdictional and procedural frameworks are distinct.

MDL vs. Coordination in State Court: Most states have counterpart coordination mechanisms — California's Judicial Council Coordination Proceedings (JCCP) being the most prominent — but these operate exclusively in state court under state rules. Federal MDL is limited to cases that independently satisfy federal court jurisdiction, primarily diversity of citizenship under 28 U.S.C. § 1332 or federal question jurisdiction under 28 U.S.C. § 1331.

Tradeoffs and Tensions

Efficiency vs. Individual Plaintiff Autonomy

Centralization accelerates discovery and reduces duplicative expert costs, but individual plaintiffs exercise limited direct control over litigation strategy. PSC decisions about which expert witnesses to retain, what discovery to pursue, and when to negotiate bind the entire plaintiff pool even though individual plaintiffs had no vote in those choices.

Global Settlement Pressure

Bellwether verdicts create pressure toward global settlement. Defendants facing large verdicts in representative trials have incentive to resolve all pending claims simultaneously, but plaintiffs with stronger individual facts may receive less than their cases would command in independent litigation. The settlement process in MDL context operates more like a portfolio negotiation than a case-specific valuation.

Venue and Choice of Law Complications

MDL consolidates cases but does not unify the applicable substantive law. The transferee court applies the conflict-of-law rules of each originating district — a principle established by the Supreme Court in Lexecon Inc. v. Milberg Weiss Bershad Hynes & Lerach, 523 U.S. 26 (1998). This means a single MDL may involve dozens of different state tort standards on issues such as comparative fault, damages caps, and statute of limitations, creating substantial case management complexity.

Common Benefit Fee Disputes

PSC counsel who generate work product benefiting all plaintiffs are compensated through a "common benefit" fee assessed against individual settlements — typically 4 to 8 percent, depending on court order. These assessments generate friction between PSC attorneys and individual plaintiff attorneys whose clients are charged fees for work product they did not commission.

Common Misconceptions

Misconception: MDL is the same as a class action.
MDL does not certify a class. Each plaintiff retains an individual case and must individually agree to any settlement. The Rule 23 requirements — commonality, typicality, adequacy — are not prerequisites for MDL transfer.

Misconception: Winning an MDL means all plaintiffs automatically recover.
MDL centralizes pretrial management; it does not produce a single unified verdict. Plaintiffs who do not settle must have their individual cases remanded and tried separately. A defense verdict in a bellwether trial does not extinguish other plaintiffs' claims.

Misconception: MDL plaintiffs lose their original venue.
Transfer under § 1407 is for pretrial purposes only. Cases are returned to their originating districts if they go to trial. The Supreme Court's Lexecon decision confirmed that transferee judges cannot self-assign cases for trial by invoking 28 U.S.C. § 1404 after the pretrial phase concludes.

Misconception: MDL always results in faster resolution.
While discovery consolidation reduces redundancy, large MDLs involving tens of thousands of plaintiffs can remain pending for 10 or more years. The opioid MDL (In re: National Prescription Opiate Litigation, MDL No. 2804) was initiated in 2017 and continued to generate significant settlement activity through 2023.

Checklist or Steps (Non-Advisory)

The following describes the procedural sequence through which a federal MDL proceeding is established and administered. This is a descriptive reference, not legal guidance.

Phase 1 — Petition and Panel Review
- [ ] Party files motion to transfer with the JPML under 28 U.S.C. § 1407
- [ ] JPML dockets the motion and sets a briefing schedule
- [ ] Affected parties file responses (support, opposition, or alternative district proposals)
- [ ] JPML holds oral argument at a scheduled hearing session
- [ ] JPML issues Conditional Transfer Order (CTO) or denies transfer

Phase 2 — Centralization and Organization
- [ ] Transferee judge assigned by JPML
- [ ] Initial case management conference scheduled under Federal Rule of Civil Procedure 16
- [ ] Plaintiffs' Steering Committee applications solicited and evaluated
- [ ] Defense liaison structure established
- [ ] Case management order issued governing discovery schedule, document production protocols, and bellwether selection criteria

Phase 3 — Coordinated Discovery
- [ ] Master discovery requests served covering core liability facts
- [ ] Defendant document productions governed by ESI (electronically stored information) protocols
- [ ] Common benefit expert witnesses retained and reports disclosed
- [ ] Daubert challenges to expert admissibility briefed and argued (see admissibility of evidence)

Phase 4 — Bellwether Trials or Global Resolution
- [ ] Bellwether pool selected through stipulation or court-ordered process
- [ ] Individual bellwether cases tried to verdict
- [ ] Global settlement negotiations conducted using verdict data
- [ ] Individual plaintiff consent obtained for each settling case
- [ ] Common benefit fee allocation determined by court order

Phase 5 — Remand or Termination
- [ ] Unsettled cases remanded to originating districts under § 1407(a)
- [ ] JPML issues remand order
- [ ] Originating district courts resume individual case management

Reference Table or Matrix

Feature MDL (28 U.S.C. § 1407) Class Action (FRCP 23) State Coordination (e.g., JCCP)
Governing authority Federal statute Federal rule State procedural rules
Plaintiff binding Individual consent required Absent members bound (with opt-out right) Varies by state
Certification required No Yes (commonality, typicality, adequacy) Varies
Scope Federal cases only Federal or state State court only
Trial venue Remand to originating district Transferee court Coordinating court
Applicable substantive law Originating district's conflict-of-law rules (Lexecon) Transferee court rules Coordinating court rules
Leadership structure Plaintiffs' Steering Committee Lead/class counsel Varies
Common use cases Mass tort, pharmaceutical, product liability Consumer fraud, securities, employment Pharmaceutical, product liability, construction defect
Resolution mechanism Bellwether trials + global settlement Class settlement (requires court approval) Coordination + settlement or trial
Governing JPML Yes No No

References

📜 6 regulatory citations referenced  ·  🔍 Monitored by ANA Regulatory Watch  ·  View update log

Explore This Site

Regulations & Safety Regulatory References Tools & Calculators Attorney Fee Estimator